The Kingston General Hospital site is an acute-care teaching hospital affiliated with Queen's University located in Kingston, Ontario, Canada.

During the past decade, Kingston General Hospital conducted 225 clinical trials. In the 10-year time frame, 225 clinical trials started and 70 clinical trials were completed, i.e. on average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 47 clinical trials were completed. i.e. 54% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kingston General Hospital" #1 sponsor was "Queen's University" with 60 trials, followed by "Children's Oncology Group" with 40 trials sponsored, "National Cancer Institute (NCI)" with 27 trials sponsored, "Canadian Cancer Trials Group" with 24 trials sponsored and "McMaster University" with 24 trials sponsored. Other sponsors include 211 different institutions and companies that sponsored additional 108 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kingston General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 45 trials as a collaborator, "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Queen's University" with 15 trials as a collaborator, "The Physicians' Services Incorporated Foundation" with 13 trials as a collaborator and "AstraZeneca" with 12 trials as a collaborator. Other collaborators include 318 different institutions and companies that were collaborators in the rest 229 trials.

According to Clinical.Site data, the most researched conditions in "Kingston General Hospital" are "Atrial Fibrillation" (19 trials), "Critical Illness" (11 trials), "Asthma" (9 trials), "Stroke" (7 trials) and "Acute Lymphoblastic Leukemia" (6 trials). Many other conditions were trialed in "Kingston General Hospital" in a lesser frequency.

Most popular intervention types in "Kingston General Hospital" are "Drug" (198 trials), "Other" (115 trials), "Procedure" (54 trials), "Device" (43 trials) and "Biological" (42 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Laboratory Biomarker Analysis" (37 trials), "Cyclophosphamide" (28 trials), "Vincristine Sulfate" (24 trials) and "Doxorubicin Hydrochloride" (19 trials). Other intervention names were less common.

The vast majority of trials in "Kingston General Hospital" are 344 trials for "All" genders, 30 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Kingston General Hospital". 4 are not yet recruiting, 85 are recruiting, 84 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 155 completed trials in Kingston General Hospital, 4 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Kingston General Hospital, 12 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 38 trials, and there were also 86 trials that are defined as “Not Applicable".

Kingston General Hospital has several departments that took part in Clinical trials: "Respiratory Investigation Unit, Kingston General Hospital" - 12 trials, "Cancer Centre of Southeastern Ontario at Kingston General Hospital" - 178 trials